$GBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Generation Bio Co..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Generation Bio Co.. Get notifications about new insider transactions in Generation Bio Co. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 100,000 | 0 | 1,266,937 | 1.4 M to 1.3 M (-7.32 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 100,000 | 0 | 1,266,937 | 1.4 M to 1.3 M (-7.32 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,111,939 | 9.1 M to 8.1 M (-10.97 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,111,939 | 9.1 M to 8.1 M (-10.97 %) |
| Apr 27 2021 | GBIO | Generation Bio Co. | MCDONOUGH GEOFF | PRESIDENT AND CEO | Sell | S | 35.10 | 10,000 | 351,000 | 1,184,080 | 1.2 M to 1.2 M (-0.84 %) |
| Apr 23 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Option Exercise | M | 4.59 | 2,500 | 11,475 | 88,907 | |
| Apr 23 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Sell | S | 33.32 | 2,500 | 83,300 | 0 | 2.5 K to 0 (-100.00 %) |
| Apr 23 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Buy | M | 4.59 | 2,500 | 11,475 | 2,500 | 0 to 2.5 K |
| Apr 23 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | M | 0.60 | 1,500 | 900 | 25,194 | |
| Apr 23 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | M | 0.60 | 1,500 | 900 | 26,694 | |
| Apr 23 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 34.03 | 1,500 | 51,045 | 198,154 | 199.7 K to 198.2 K (-0.75 %) |
| Apr 23 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Buy | M | 0.60 | 1,500 | 900 | 199,654 | 198.2 K to 199.7 K (+0.76 %) |
| Apr 23 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 31.07 | 1,500 | 46,605 | 198,154 | 199.7 K to 198.2 K (-0.75 %) |
| Apr 23 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Buy | M | 0.60 | 1,500 | 900 | 199,654 | 198.2 K to 199.7 K (+0.76 %) |
| Apr 20 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | M | 0.60 | 1,500 | 900 | 28,194 | |
| Apr 20 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 28.03 | 1,500 | 42,045 | 198,154 | 199.7 K to 198.2 K (-0.75 %) |
| Apr 20 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Buy | M | 0.60 | 1,500 | 900 | 199,654 | 198.2 K to 199.7 K (+0.76 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 26.78 | 12,874 | 344,766 | 0 | 12.9 K to 0 (-100.00 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 26.40 | 10,539 | 278,230 | 12,874 | 23.4 K to 12.9 K (-45.01 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 25.53 | 7,354 | 187,748 | 23,413 | 30.8 K to 23.4 K (-23.90 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 25.09 | 35,791 | 897,996 | 30,767 | 66.6 K to 30.8 K (-53.77 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 26.61 | 10,771 | 286,616 | 66,558 | 77.3 K to 66.6 K (-13.93 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 26.07 | 63,353 | 1,651,613 | 77,329 | 140.7 K to 77.3 K (-45.03 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 26.78 | 12,874 | 344,766 | 0 | 12.9 K to 0 (-100.00 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 26.40 | 10,539 | 278,230 | 12,874 | 23.4 K to 12.9 K (-45.01 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 25.53 | 7,354 | 187,748 | 23,413 | 30.8 K to 23.4 K (-23.90 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 25.09 | 35,791 | 897,996 | 30,767 | 66.6 K to 30.8 K (-53.77 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 26.61 | 10,771 | 286,616 | 66,558 | 77.3 K to 66.6 K (-13.93 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 26.07 | 63,353 | 1,651,613 | 77,329 | 140.7 K to 77.3 K (-45.03 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | M | 0.60 | 6,000 | 3,600 | 29,694 | |
| Apr 14 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 26.78 | 1,100 | 29,458 | 198,154 | 199.3 K to 198.2 K (-0.55 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 26.12 | 4,900 | 127,988 | 199,254 | 204.2 K to 199.3 K (-2.40 %) |
| Apr 14 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Buy | M | 0.60 | 6,000 | 3,600 | 204,154 | 198.2 K to 204.2 K (+3.03 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.35 | 2,132 | 60,442 | 140,682 | 142.8 K to 140.7 K (-1.49 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.35 | 2,132 | 60,442 | 140,682 | 142.8 K to 140.7 K (-1.49 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 27.57 | 41,549 | 1,145,506 | 142,814 | 184.4 K to 142.8 K (-22.54 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 27.57 | 41,549 | 1,145,506 | 142,814 | 184.4 K to 142.8 K (-22.54 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.90 | 3,191 | 92,220 | 184,363 | 187.6 K to 184.4 K (-1.70 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.90 | 3,191 | 92,220 | 184,363 | 187.6 K to 184.4 K (-1.70 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.47 | 40,359 | 1,149,021 | 187,554 | 227.9 K to 187.6 K (-17.71 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.47 | 40,359 | 1,149,021 | 187,554 | 227.9 K to 187.6 K (-17.71 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 29.19 | 1,894 | 55,286 | 227,913 | 229.8 K to 227.9 K (-0.82 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 29.19 | 1,894 | 55,286 | 227,913 | 229.8 K to 227.9 K (-0.82 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.48 | 37,970 | 1,081,386 | 229,807 | 267.8 K to 229.8 K (-14.18 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 28.48 | 37,970 | 1,081,386 | 229,807 | 267.8 K to 229.8 K (-14.18 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.35 | 2,132 | 60,442 | 140,682 | 142.8 K to 140.7 K (-1.49 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.35 | 2,132 | 60,442 | 140,682 | 142.8 K to 140.7 K (-1.49 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 27.57 | 41,549 | 1,145,506 | 142,814 | 184.4 K to 142.8 K (-22.54 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 27.57 | 41,549 | 1,145,506 | 142,814 | 184.4 K to 142.8 K (-22.54 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.90 | 3,191 | 92,220 | 184,363 | 187.6 K to 184.4 K (-1.70 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.90 | 3,191 | 92,220 | 184,363 | 187.6 K to 184.4 K (-1.70 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.47 | 40,359 | 1,149,021 | 187,554 | 227.9 K to 187.6 K (-17.71 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.47 | 40,359 | 1,149,021 | 187,554 | 227.9 K to 187.6 K (-17.71 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 29.19 | 1,894 | 55,286 | 227,913 | 229.8 K to 227.9 K (-0.82 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 29.19 | 1,894 | 55,286 | 227,913 | 229.8 K to 227.9 K (-0.82 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.48 | 37,970 | 1,081,386 | 229,807 | 267.8 K to 229.8 K (-14.18 %) |
| Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | S | 28.48 | 37,970 | 1,081,386 | 229,807 | 267.8 K to 229.8 K (-14.18 %) |
| Mar 18 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 9,111,939 | 10.1 M to 9.1 M (-9.89 %) |
| Mar 12 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | M | 0.60 | 10,500 | 6,300 | 35,694 | |
| Mar 12 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 35.28 | 5,950 | 209,916 | 198,154 | 204.1 K to 198.2 K (-2.92 %) |
| Mar 12 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 34.57 | 4,550 | 157,294 | 204,104 | 208.7 K to 204.1 K (-2.18 %) |
| Mar 12 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Buy | M | 0.60 | 10,500 | 6,300 | 208,654 | 198.2 K to 208.7 K (+5.30 %) |
| Mar 05 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Option Exercise | M | 4.59 | 3,000 | 13,770 | 91,407 | |
| Mar 05 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Sell | S | 41.38 | 3,000 | 124,140 | 0 | 3 K to 0 (-100.00 %) |
| Mar 05 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Buy | M | 4.59 | 3,000 | 13,770 | 3,000 | 0 to 3 K |
| Mar 03 2021 | GBIO | Generation Bio Co. | Cooper Ronald Harold Wilfred | Option Exercise | A | 40.20 | 30,000 | 1,206,000 | 30,000 | ||
| Feb 05 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | A | 30.73 | 30,000 | 921,900 | 30,000 | |
| Feb 05 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | A | 30.25 | 73,500 | 2,223,375 | 73,500 | |
| Feb 05 2021 | GBIO | Generation Bio Co. | Norkunas Matthew | CHIEF FINANCIAL OFF ... | Option Exercise | A | 30.73 | 6,100 | 187,453 | 6,100 | |
| Feb 05 2021 | GBIO | Generation Bio Co. | Norkunas Matthew | CHIEF FINANCIAL OFF ... | Option Exercise | A | 30.25 | 32,823 | 992,896 | 32,823 | |
| Feb 04 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Option Exercise | M | 4.59 | 2,500 | 11,475 | 96,907 | |
| Feb 04 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Option Exercise | A | 30.25 | 29,478 | 891,710 | 29,478 | |
| Feb 04 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Sell | S | 33.05 | 2,500 | 82,625 | 0 | 2.5 K to 0 (-100.00 %) |
| Feb 04 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Buy | M | 4.59 | 2,500 | 11,475 | 2,500 | 0 to 2.5 K |
| Jan 20 2021 | GBIO | Generation Bio Co. | Angelino Mark D. | CHIEF OPERATING OFF ... | Option Exercise | M | 4.59 | 7,500 | 34,425 | 110,960 | |
| Jan 20 2021 | GBIO | Generation Bio Co. | Angelino Mark D. | CHIEF OPERATING OFF ... | Sell | S | 34.96 | 600 | 20,976 | 345,637 | 346.2 K to 345.6 K (-0.17 %) |
| Jan 20 2021 | GBIO | Generation Bio Co. | Angelino Mark D. | CHIEF OPERATING OFF ... | Sell | S | 34.12 | 500 | 17,060 | 346,237 | 346.7 K to 346.2 K (-0.14 %) |
| Jan 20 2021 | GBIO | Generation Bio Co. | Angelino Mark D. | CHIEF OPERATING OFF ... | Sell | S | 33.18 | 2,900 | 96,222 | 346,737 | 349.6 K to 346.7 K (-0.83 %) |
| Jan 20 2021 | GBIO | Generation Bio Co. | Angelino Mark D. | CHIEF OPERATING OFF ... | Sell | S | 32.29 | 3,500 | 113,015 | 349,637 | 353.1 K to 349.6 K (-0.99 %) |
| Jan 20 2021 | GBIO | Generation Bio Co. | Angelino Mark D. | CHIEF OPERATING OFF ... | Buy | M | 4.59 | 7,500 | 34,425 | 353,137 | 345.6 K to 353.1 K (+2.17 %) |
| Jan 15 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Option Exercise | M | 4.59 | 2,500 | 11,475 | 99,407 | |
| Jan 15 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Sell | S | 33.09 | 2,500 | 82,725 | 0 | 2.5 K to 0 (-100.00 %) |
| Jan 15 2021 | GBIO | Generation Bio Co. | Zimmermann Tracy | CHIEF DEVELOPMENT O ... | Buy | M | 4.59 | 2,500 | 11,475 | 2,500 | 0 to 2.5 K |
| Jan 15 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | M | 0.60 | 5,630 | 3,378 | 56,594 | |
| Jan 15 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 34.00 | 2,790 | 94,860 | 198,154 | 200.9 K to 198.2 K (-1.39 %) |
| Jan 15 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 31.11 | 2,840 | 88,352 | 200,944 | 203.8 K to 200.9 K (-1.39 %) |
| Jan 15 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Buy | M | 0.60 | 5,630 | 3,378 | 203,784 | 198.2 K to 203.8 K (+2.84 %) |
| Jan 15 2021 | GBIO | Generation Bio Co. | MCDONOUGH GEOFF | PRESIDENT AND CEO | Gift | G | 0.00 | 275,000 | 0 | 275,000 | 0 to 275 K |
| Jan 15 2021 | GBIO | Generation Bio Co. | MCDONOUGH GEOFF | PRESIDENT AND CEO | Gift | G | 0.00 | 275,000 | 0 | 1,204,080 | 1.5 M to 1.2 M (-18.59 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Kerr Douglas | CHIEF MEDICAL OFFIC ... | Option Exercise | M | 4.59 | 11,267 | 51,716 | 112,493 | |
| Jan 13 2021 | GBIO | Generation Bio Co. | Kerr Douglas | CHIEF MEDICAL OFFIC ... | Sell | S | 28.80 | 300 | 8,640 | 326,558 | 326.9 K to 326.6 K (-0.09 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Kerr Douglas | CHIEF MEDICAL OFFIC ... | Sell | S | 28.05 | 4,721 | 132,424 | 326,858 | 331.6 K to 326.9 K (-1.42 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Kerr Douglas | CHIEF MEDICAL OFFIC ... | Sell | S | 27.17 | 6,246 | 169,704 | 331,579 | 337.8 K to 331.6 K (-1.85 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Kerr Douglas | CHIEF MEDICAL OFFIC ... | Buy | M | 4.59 | 11,267 | 51,716 | 337,825 | 326.6 K to 337.8 K (+3.45 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Option Exercise | M | 0.60 | 14,820 | 8,892 | 62,224 | |
| Jan 13 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 28.77 | 509 | 14,644 | 198,154 | 198.7 K to 198.2 K (-0.26 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 28.02 | 8,042 | 225,337 | 198,663 | 206.7 K to 198.7 K (-3.89 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Sell | S | 27.18 | 6,269 | 170,391 | 206,705 | 213 K to 206.7 K (-2.94 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Stanton Matthew | CHIEF SCIENTIFIC OF ... | Buy | M | 0.60 | 14,820 | 8,892 | 212,974 | 198.2 K to 213 K (+7.48 %) |
| Jan 13 2021 | GBIO | Generation Bio Co. | Nicholson Donald William | Buy | P | 24.50 | 4,081 | 99,985 | 103,157 | 99.1 K to 103.2 K (+4.12 %) | |
| Jan 13 2021 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Buy | P | 24.50 | 20,408 | 499,996 | 101,035 | 80.6 K to 101 K (+25.31 %) | |
| Dec 17 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,151,882 | 0 | 11,478,876 | 12.6 M to 11.5 M (-9.12 %) |
| Dec 17 2020 | GBIO | Generation Bio Co. | Angelino Mark D. | Chief Operating Off ... | Option Exercise | M | 4.59 | 5,301 | 24,332 | 118,460 | |
| Dec 17 2020 | GBIO | Generation Bio Co. | Angelino Mark D. | Chief Operating Off ... | Sell | S | 35.52 | 900 | 31,968 | 345,637 | 346.5 K to 345.6 K (-0.26 %) |
| Dec 17 2020 | GBIO | Generation Bio Co. | Angelino Mark D. | Chief Operating Off ... | Sell | S | 34.87 | 4,401 | 153,463 | 346,537 | 350.9 K to 346.5 K (-1.25 %) |
| Dec 17 2020 | GBIO | Generation Bio Co. | Angelino Mark D. | Chief Operating Off ... | Buy | M | 4.59 | 5,301 | 24,332 | 350,938 | 345.6 K to 350.9 K (+1.53 %) |
| Dec 14 2020 | GBIO | Generation Bio Co. | Stanton Matthew | Chief Scientific Of ... | Option Exercise | M | 0.60 | 10,540 | 6,324 | 77,044 | |
| Dec 14 2020 | GBIO | Generation Bio Co. | Stanton Matthew | Chief Scientific Of ... | Sell | S | 38.62 | 820 | 31,668 | 198,154 | 199 K to 198.2 K (-0.41 %) |
| Dec 14 2020 | GBIO | Generation Bio Co. | Stanton Matthew | Chief Scientific Of ... | Sell | S | 38.01 | 4,402 | 167,320 | 198,974 | 203.4 K to 199 K (-2.16 %) |
| Dec 14 2020 | GBIO | Generation Bio Co. | Stanton Matthew | Chief Scientific Of ... | Sell | S | 37.14 | 5,318 | 197,511 | 203,376 | 208.7 K to 203.4 K (-2.55 %) |
| Dec 14 2020 | GBIO | Generation Bio Co. | Stanton Matthew | Chief Scientific Of ... | Buy | M | 0.60 | 10,540 | 6,324 | 208,694 | 198.2 K to 208.7 K (+5.32 %) |
| Aug 18 2020 | GBIO | Generation Bio Co. | Angelino Mark D. | Chief Operating Off ... | Option Exercise | M | 0.60 | 62,560 | 37,536 | 37,536 | |
| Aug 18 2020 | GBIO | Generation Bio Co. | Angelino Mark D. | Chief Operating Off ... | Buy | M | 0.60 | 62,560 | 37,536 | 345,637 | 283.1 K to 345.6 K (+22.10 %) |
| Jul 24 2020 | GBIO | Generation Bio Co. | Norkunas Matthew | Chief Financial Off ... | Option Exercise | A | 21.41 | 330,000 | 7,065,300 | 330,000 | |
| Jul 24 2020 | GBIO | Generation Bio Co. | Norkunas Matthew | Chief Financial Off ... | Option Exercise | A | 21.41 | 330,000 | 7,065,300 | 330,000 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Christensen Gustav | Director | Option Exercise | C | 0.00 | 44,711 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Christensen Gustav | Director | Option Exercise | C | 0.00 | 10,934 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Christensen Gustav | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Christensen Gustav | Director | Buy | C | 0.00 | 88,961 | 0 | 131,422 | 42.5 K to 131.4 K (+209.51 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Wellington Biomedical Innovati ... | 10% Owner | Option Exercise | C | 0.00 | 1,788,460 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Wellington Biomedical Innovati ... | 10% Owner | Buy | P | 19.00 | 1,100,000 | 20,900,000 | 2,112,546 | 1 M to 2.1 M (+108.64 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Wellington Biomedical Innovati ... | 10% Owner | Buy | C | 0.00 | 1,012,546 | 0 | 1,012,546 | 0 to 1 M |
| Jun 18 2020 | GBIO | Generation Bio Co. | MCDONOUGH GEOFF | See Remarks | Option Exercise | C | 0.00 | 200,000 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | MCDONOUGH GEOFF | See Remarks | Buy | C | 0.00 | 113,231 | 0 | 1,479,080 | 1.4 M to 1.5 M (+8.29 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,073,076 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,186,820 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Buy | P | 19.00 | 800,000 | 15,200,000 | 2,814,191 | 2 M to 2.8 M (+39.72 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Buy | C | 0.00 | 2,014,191 | 0 | 2,014,191 | 0 to 2 M |
| Jun 18 2020 | GBIO | Generation Bio Co. | Stehman-Breen Catherine | Director | Option Exercise | C | 0.00 | 8,942 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Stehman-Breen Catherine | Director | Buy | C | 0.00 | 5,062 | 0 | 47,523 | 42.5 K to 47.5 K (+11.92 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Quinn Anthony G. | Director | Option Exercise | C | 0.00 | 53,654 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Quinn Anthony G. | Director | Buy | C | 0.00 | 30,376 | 0 | 72,837 | 42.5 K to 72.8 K (+71.54 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Nicholson Donald William | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Nicholson Donald William | Director | Buy | C | 0.00 | 56,615 | 0 | 99,076 | 42.5 K to 99.1 K (+133.33 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Option Exercise | C | 0.00 | 89,423 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Buy | P | 19.00 | 30,000 | 570,000 | 80,627 | 50.6 K to 80.6 K (+59.26 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Buy | C | 0.00 | 50,627 | 0 | 50,627 | 0 to 50.6 K |
| Jun 18 2020 | GBIO | Generation Bio Co. | Casdin Capital, LLC | 10% Owner | Option Exercise | C | 0.00 | 455,500 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Casdin Capital, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,093,410 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Casdin Capital, LLC | 10% Owner | Buy | P | 19.00 | 650,000 | 12,350,000 | 1,611,215 | 961.2 K to 1.6 M (+67.62 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Casdin Capital, LLC | 10% Owner | Buy | C | 0.00 | 961,215 | 0 | 961,215 | 0 to 961.2 K |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Option Exercise | C | 0.00 | 2,683 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Option Exercise | C | 0.00 | 15,051,020 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Buy | C | 0.00 | 10,040,032 | 0 | 12,630,758 | 2.6 M to 12.6 M (+387.54 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 268,269 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 15,051,020 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 10,040,032 | 0 | 12,630,758 | 2.6 M to 12.6 M (+387.54 %) |
| Jun 17 2020 | GBIO | Generation Bio Co. | Zone Healthcare Holdings, LLC | Option Exercise | C | 0.00 | 2,682,691 | 0 | 0 | ||
| Jun 17 2020 | GBIO | Generation Bio Co. | Zone Healthcare Holdings, LLC | Buy | P | 19.00 | 400,000 | 7,600,000 | 1,918,819 | 1.5 M to 1.9 M (+26.34 %) | |
| Jun 17 2020 | GBIO | Generation Bio Co. | Zone Healthcare Holdings, LLC | Buy | C | 0.00 | 1,518,819 | 0 | 1,518,819 | 0 to 1.5 M |